Axsome Therapeutics Inc

1AXSM

Company Profile

  • Business description

    Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

  • Contact

    One World Trade Center
    22nd Floor
    New YorkNY10007
    USA

    T: +1 212 332-3241

    E: [email protected]

    https://www.axsome.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    589

Stocks News & Analysis

stocks

WiseTech result disappoints, but the future looks bright

Markets appear underwhelmed by recent sales growth, however, our kingmaker thesis is intact.
stocks

WOW earnings: Woolworths losing market share, but will catch up to Coles

Woolworths have had a soft start to a challenging year, but Morningstar analyst believes it will eventually catch up to its main competitor.
stocks

Chart of the Week: Largest share price falls during earnings

Opportunities arise when the market overreacts, and good quality companies are mispriced.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,231.809.80-0.11%
CAC 407,743.9334.120.44%
DAX 4024,046.21106.66-0.44%
Dow JONES (US)45,565.23147.160.32%
FTSE 1009,255.5010.30-0.11%
HKSE25,035.78165.98-0.66%
NASDAQ21,590.1445.870.21%
Nikkei 22542,742.36222.090.52%
NZX 50 Index12,905.4243.580.34%
S&P 5006,481.4015.460.24%
S&P/ASX 2008,970.200.30-0.00%
SSE Composite Index3,803.082.730.07%

Market Movers